Intellectual Property

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

  • June 16, 2026

    Amazon Says YouTubers' DMCA Suit Rests On 'Guesswork'

    Amazon has urged a Seattle federal court to toss three YouTube creators' proposed Digital Millennium Copyright Act class action that accuses the e-commerce giant of scraping millions of copyright-protected videos to train its generative artificial intelligence model Nova Reel, saying the YouTubers' failure to link it to certain datasets makes their allegations "entirely speculative."

  • June 16, 2026

    Del. Judge Won't Touch Jury's $83M Diagnostics IP Verdict

    A Delaware federal judge on Tuesday upheld a jury's 2023 verdict finding that Guardant Health Inc. should pay TwinStrand Biosciences Inc. $83.4 million for willfully infringing diagnostic patents, refusing to overturn or enhance the award.

  • June 16, 2026

    Justices Asked To Revive $77M In Trade Secret Damages

    Plastics manufacturer Trinseo Europe GmbH has asked the U.S. Supreme Court to restore a verdict of more than $77 million that it won stemming from trade secret misappropriation allegations against a former Dow Chemical Co. employee and engineering firm KBR, saying the Fifth Circuit went against precedent when it endorsed an approach to damages that "is the antithesis of flexible."

  • June 16, 2026

    Game-Maker Seeks $13.5M Over Alleged Counterfeits

    The maker of Fusion skill game platforms has accused a Philadelphia route operator and his company of selling hacked and counterfeit versions of its game systems on eBay and Facebook Marketplace, alleging in a federal lawsuit that the knockoffs duplicate its copyrighted artwork and registered trademarks.

  • June 16, 2026

    ITC To Review Hoverboard Patent Infringement Decision

    The U.S. International Trade Commission said Tuesday that it will review portions of an administrative law judge's decision finding two companies infringed two Razor USA LLC patents for self-balancing hoverboards.

  • June 16, 2026

    Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

    A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.

  • June 16, 2026

    'Peanuts' Copyright Gag In Colbert Finale Ends In Donation

    The steward of the "Peanuts" television and film music catalog announced Tuesday it will donate the proceeds of a licensing agreement with CBS after Stephen Colbert's band "illegally" played the "Linus and Lucy" tune as a gag in the final broadcast of "The Late Show."

  • June 16, 2026

    Book Publishers Want WeLib 'Shadow Library' Dismantled

    A group of large book and text publishers is suing to dismantle WeLib, an online "shadow library" that the publishers said was built off the "notorious pirate site" Anna's Archive.

  • June 16, 2026

    Carnegie Mellon, LSI Settle Ahead Of Memory Patent Trial

    Carnegie Mellon University has settled patent infringement claims it brought against an indirect subsidiary of Broadcom Inc. related to memory storage technology.

  • June 16, 2026

    Monolithic Wins Bid To Send Patent Case From WDTX To Calif.

    A Texas federal judge has shipped a suit accusing Monolithic Power Systems of infringing a power conversion patent to California, finding that neither the power management parts maker nor the patent owner is based in Texas.

  • June 16, 2026

    Ex-Wine Exec Says Privilege Covers Atty Emails With Spouse

    The former president of a company connected to the Josh Cellars wine brand says his attorney's messages to his wife are privileged because she participated in the communications as his "agent," a characterization the company appeared poised to dispute as the parties approach a $4 million trademark royalties trial.

  • June 16, 2026

    4th Circ. Turns Down Bacardi Challenge To Rum TM Renewal

    The Fourth Circuit on Tuesday rejected Bacardi's challenge to the U.S. Patent and Trademark Office's renewal of a Cuban company's expired trademark registration for Havana Club rum, finding a retroactive approval to pay the registration fee to be valid.

  • June 16, 2026

    Software Co. Says Exec Is Taking Trade Secrets To Rival

    Software company EnterpriseDB asked a Massachusetts judge to stop a former vice president from jumping to competitor Couchbase, citing both a noncompete agreement and evidence that he downloaded hundreds of documents prior to his departure.

  • June 16, 2026

    These Firms Secured The Most Damages In The Last 3 Years

    Government lawyers had a strong success rate in federal courts over the last three years, but intellectual property litigation saw certain firms secure damage awards worth hundreds of millions of dollars for clients, according to Lex Machina's Law Firms Activity Report 2026 released on Tuesday.

  • June 15, 2026

    Tyra Banks Sues Netflix For 'False Narrative' In 'Top Model' Doc

    Tyra Banks has filed a defamation suit against Netflix, which she said constructed a "false narrative" in its docuseries about the supermodel's hit television show "America's Next Top Model," including suggesting that a young woman on the show was sexually assaulted and Banks did nothing.

  • June 15, 2026

    Newman's Appeal Loss Shows Limits On Suspension Reviews

    The U.S. Supreme Court's rejection on Monday of Federal Circuit Judge Pauline Newman's appeal in the long-running dispute over her suspension made clear that the available routes to challenge such orders are narrow, and spurred critics to contemplate ways to revise the system.

  • June 15, 2026

    Cognizant, Infosys Can't Shield Execs From Depositions

    Infosys Ltd. and Cognizant TriZetto Software Group Inc. will each have to produce executives to speak on certain topics for depositions in a Texas federal lawsuit over claims that Infosys stole Cognizant's trade secrets to build a competing healthcare software, a special master ruled Monday.

  • June 15, 2026

    Squires Rejects 7 AIA Cases, Explains Earlier Tesla Decision

    U.S. Patent and Trademark Office Director John Squires has granted five patent challenges and rejected seven others, and he also issued a decision Monday explaining why he allowed a group of Tesla petitions to go ahead to the merits stage of review.

  • June 15, 2026

    Fed. Circ. Declines To Revive Medmix's Dentistry Patent

    The Patent Trial and Appeal Board didn't err when invalidating claims of a Medmix Switzerland AG patent used in the dentistry industry, the Federal Circuit said Monday.

  • June 15, 2026

    Judge Tosses XAI Trade Secret Case Against OpenAI

    A California federal judge on Monday dismissed xAI Corp.'s trade secret lawsuit against OpenAI without leave to amend, finding that despite updating its complaint once previously, the company still failed to plausibly allege that OpenAI knowingly obtained or used confidential information from former xAI employees.

  • June 15, 2026

    CareFirst Says Intent Standard Was Misread In Stelara Case

    CareFirst is arguing that a Virginia federal judge created a new standard for monopolization claims when he dismissed claims from the company's antitrust suit challenging Johnson & Johnson's protection of its immunosuppressive drug Stelara, arguing he misread a Fourth Circuit decision in ruling that monopolization requires a showing of specific intent.

  • June 15, 2026

    Ex-Google Worker Can't Get AI Secrets Retrial Over Jury Picks

    A California federal judge has denied one of two motions from former Google engineer Linwei Ding seeking to overturn a jury decision that convicted him of trade secret theft and economic espionage, rejecting his claim that prosecutors improperly excluded jurors of Chinese descent.

  • June 15, 2026

    ​​​​​Calif. Jury Invalidates Ugg Maker's Boot Patent In Quince Trial

    A California federal jury on Monday found that online clothing retailer Quince sold boots that ripped off Deckers Outdoor Corp.'s patented design for Ugg's Classic Ultra Mini Boot, but agreed with the online retailer that Deckers' design patent is invalid.

  • June 15, 2026

    Home Depot, Macy's, Others Targeted In Patent Suits

    Retailers Home Depot and Macy's, and restaurant chains Flower Child and Shake Shack were among several large companies sued in Texas federal court over accusations that they infringed a set of patents covering card-reading electronics components.

Expert Analysis

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Patent Eligibility Faces Widening Gap Between USPTO, Courts

    Author Photo

    The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

  • Expect Major Shifts In Patent And Trademark Policy This Year

    Author Photo

    New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.

  • And Now A Word From The Panel: MDL Year In Review

    Author Photo

    2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.

  • Series

    Judges On AI: How Judicial Use Informs Guardrails

    Author Photo

    U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.

  • Evenflo IP Ruling Shows Evidence Is Still Key For Injunctions

    Author Photo

    Notwithstanding renewed policy and doctrinal attention to patent injunctions, the Federal Circuit's December decision in Wonderland v. Evenflo signals that the era of easily obtained patent injunctions has not yet arrived, say attorneys at King & Wood.

  • What US Cos. Must Know To Comply With Italy's AI Law

    Author Photo

    Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.

  • Navigating Battery Validation Risk In The EV Supply Chain

    Author Photo

    Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.

  • Fed. Circ. In 2025: A Look At Continued USPTO Tensions

    Author Photo

    Unanticipated developments in 2025 included a tug-of-war between the Federal Circuit and the U.S. Patent and Trademark Office over inter partes review decisions, and this continued disparity looks set to contribute to another packed year for the court, say attorneys at Knobbe Martens.

  • How 2025 Recalibrated Fair Use For The AI Era

    Author Photo

    Although the Second Circuit's decision last year in Romanova v. Amilus Inc. did not involve artificial intelligence, its formulation of relevant fair use factors provides a useful guide for lower courts examining AI cases in 2026, demanding close attention from legal practitioners on both sides of these disputes, say attorneys at Cleary.

  • Series

    Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief

    Author Photo

    My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.

  • Patent Applicants Must Get Biologics Enablement Right

    Author Photo

    As artificial intelligence increasingly becomes a core driver in drug discovery, it is critical for drug companies to adapt their drafting strategies to the unique features of AI-generated inventions, and to pay particularly close attention to enablement standards, says Sanandan Malhotra at Novo Nordisk.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.